Standard Chemical & Pharmaceutical Co (TPE:1720) 5-Year EBITDA Growth Rate : 18.60% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co 5-Year EBITDA Growth Rate?

Standard Chemical & Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was NT$2.96.

During the past 12 months, Standard Chemical & Pharmaceutical Co's average EBITDA Per Share Growth Rate was 15.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 27.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Standard Chemical & Pharmaceutical Co was 27.70% per year. The lowest was -5.60% per year. And the median was 7.25% per year.

Competitive Comparison of Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

Standard Chemical & Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Standard Chemical & Pharmaceutical Co (TPE:1720) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Standard Chemical & Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055

Website

https://www.standard.com.tw

Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines